This agreement follows the previously announced Memorandum of Understanding signed between the two parties on November 28, 2019, where OPA agreed to promote Avricore’s point-of-care testing platform, HealthTab™ + RASTR Network.
Under this agreement the Company agrees to remunerate OPA for new locations secured through facilitated introductions, plus a per test fee upon system implementation. Additionally, the two organizations will work jointly to leverage statistical data generated for research purposes to support OPA member insights and patient policy advocacy.
“This is the first partnership of this kind for us and we could not have asked for a better partner than the largest professional association of pharmacists in the country,” says Avricore Health’s CEO, Hector Bremner. “We’re looking forward to supporting even more patients access this important innovation in healthcare.”
By offering HealthTab™ to their patients, a pharmacist is able to modernize their practice through advancements in point-of-care testing, as well as address the high consumer demand for easier access to health data supporting evidence-based care.
Pharmacies that engage with Avricore agree to a two-year lease commitment of HealthTab, as well as the purchase of lipid and metabolic panels and other consumables from the Company.
“It’s clear that the entire healthcare sector is at an important moment, where social, economic and regulatory changes are having a big impact on both professionals and their patients,” says OPA CEO, Justin Bates. “Through partnerships like this, OPA members are leading the way for innovation in pharmacy.”
Pharmacies with HealthTab™ in their locations were polled to tell us the biggest advantages they found to offering the system. Here’s the top outcomes for them:
- Drives prescriptions
- Increases customer loyalty
- Increases medication review billing and other clinical services revenue
- Improves inter-professional collaboration with primary care providers
- Improves pharmacy customer service index
- Improves overall patient health through screening, chronic disease management, and medication optimization
- Improves medication adherence and frequency of script refills
- Increases traffic to pharmacy
- Increases overall pharmacy blended margin
With easier access to regular screening, patients and their healthcare teams, including their trusted pharmacist, can take action to improve health outcomes and lower the risk of serious illness.
” data-reactid=”36″>About Avricore Health Inc.
Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health. www.avricorehealth.com
https://www.opatoday.com” data-reactid=”37″>About the Ontario Pharmacists Association
The Ontario Pharmacists Association (OPA) is committed to evolving the pharmacy profession and advocating for excellence in practice and patient care. With more than 10,000 members, OPA is Canada’s largest advocacy organization and professional development provider for pharmacy professionals across Ontario. By leveraging the unique expertise of pharmacy professionals, enabling them to practise to their fullest potential, and making them more accessible to patients, OPA is working to improve the efficiency and effectiveness of the healthcare system. The pharmacy sector plays a strong role in Ontario with an economic impact of more than $ 6.3 billion across 4,500 pharmacies, employing 60,000 Ontarians. https://www.opatoday.com